top of page
Science Lab

Pioneering India's first cell and gene therapy


To be a Leader in Cell & Gene Therapy for Patients’ Long-Term Cure through Translational Research in India & beyond 

About ImmunoACT


Image by Drew Beamer

Our spectrum of expertise facilitates a minimalistic approach in developing cell and gene therapy in a pursuit to reach the unreachable

A ccessible         and affordable to all

Image by Drew Beamer

Our clinical collaboration and one-of-a-kind CAR design  platform enable us to develop novel, robust, and smarter immune cells

utting-edge research

Image by Drew Beamer

We have developed a full-stack company with domain-specific knowledge and state-of-the-art facilities for commercialisation

ransforming ideas to reality

Prof. Rahul Purwar



Atharva Karulkar


Head-Scientific programs

Shirish Arya_PNG_edited.png
Shirish Arya

Director - Strategy & Business Planning

Meet the Team

Meet the Team

Scientific Advisory Board

Carl June.webp


Parker Institute of Cancer Immunotherapy, University of Pennsylvania, USA

  • Pioneer of world's 1st CAR-T cell therapy

Avery Posey__PNG.webp
Dr. Avery D Posey, PhD

Assistant Professor

Parker Institute of Cancer Immunotherapy, University of Pennsylvania, USA

  • Expert on CAR-T for solid tumor

Gaurav Narula.webp
Dr. Gaurav Narula, MD


Tata Memorial Hospital, Mumbai

  • Leading 1st CAR-T trial of paediatric B-ALL in India

Advisory Board

Innovation Partners

Innovation Partners
Bench to bedside translation – best in class partners
  • Top rank engineering institute in India

  • Institute of Eminence status from Government of India

  • R&D Partner for technology development

  • India's  largest cancer care center

  • Leader in basic, translational and clinical cancer research

  • Partner for clinical trial and subsequent clinical studies

bottom of page